Look for:

Our offer for

BAYER AG


ISIN:
DE000BAY0017
WKN:
BAY001

2024/04/19 22:26:23
Price
26.31 EUR
Difference 0.13% (0.04)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)25,862 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)26.21 EUR (500)
Ask (Ask size)26.405 EUR (500)
Open26.00 EUR
High26.40 EUR
Low25.65 EUR
Close (prev. day)26.275 EUR
VWAP26.02578 EUR
Volume (pcs)290,626
Trading volume7,563,768.92
Number of trades1,033
Last size-

Futures and Options

Related Futures49
Related Options-

PDF Downloads

Company report: BAYER AGPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/04/19 22:26:23
Price
26.31 EUR
Difference 0.13% (0.04)

General attributes

ISINDE000BAY0017
SymbolBAYN
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)25,862 EUR
BenchmarkGERMANY DAX

Market data

Bid (Bid size)26.21 EUR (500)
Ask (Ask size)26.405 EUR (500)
Open26.00 EUR
High26.40 EUR
Low25.65 EUR
Close (prev. day)26.275 EUR
VWAP26.02578 EUR
Volume (pcs)290,626
Trading volume7,563,768.92
Number of trades1,033
Last size-

Performance and Risk

6m1Y3Y
Perf (%)-37.16%-56.87%-52.15%
Perf (abs.)-15.61-34.81-28.77
Beta1.151.080.77
Volatility39.8632.4329.12
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)26.27 EUR (261,054)
Ø price 30 days | Ø volume 30 days (pcs.)26.94 EUR (366,433)
Ø price 100 days | Ø volume 100 days (pcs.)29.84 EUR (502,828)
Ø price 250 days | Ø volume 250 days (pcs.)41.22 EUR (334,579)
YTD High | date36.09 EUR (2024/01/08)
YTD Low | date24.99 EUR (2024/03/07)
52 Weeks High | date61.47 EUR (2023/04/20)
52 Weeks Low | date24.99 EUR (2024/03/07)

All listings for BAYER AG

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2024/04/1917:3726.325 EUR109.979,091
Vienna Stock Exchange2024/04/1917:3226.295 EUR0.014
Tradegate2024/04/1922:2626.31 EUR7.561,033
Stuttgart2024/04/1921:5926.205 EUR1.93296
SIX Swiss Exchange2023/02/2117:3560.00 EUR0.001
SIX Swiss Exchange2024/02/2617:35190.00 CHF0.001
Munich2024/04/1918:0826.28 EUR0.0810
London Stock Exchange European Trade Reporting2024/04/1917:3026.335 EUR0.038
Hanover2024/04/1908:1626.015 EUR0.001
Hamburg2024/04/1919:4326.295 EUR0.048
Frankfurt2024/04/1917:5726.295 EUR0.1841
FINRA other OTC Issues2024/04/1921:4528.2063 USD0.4062
Euronext Milan MTF Trading After Hours2024/04/1818:4426.03 EUR0.036
Euronext Milan MTF Global Equity Market2024/04/1917:4426.22 EUR0.75189
Duesseldorf2024/04/1919:3126.275 EUR0.0211
Budapest Stock Exchange2024/04/1917:1910,250.00 HUF0.211
Bucharest Stock Exchange2024/04/1913:09128.60 RON0.029
Berlin2024/04/1921:5226.21 EUR0.1122

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=958&ID_TYPE_IMAGE_LOGO=2

Contact Details

BAYER AG
- -
Kaiser-Wilhelm-Allee 1 - 51368 Leverkusen
Telefon: +49-214-30-1
Fax: +
E-mail: -

PDF Downloads

Company report: BAYER AGPDF Download

Company Profile

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and womenšs health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Members of Management Board

B. Chuck AndersonChairman of Managing Board
Heike PrinzMember of Executive Committee
Heiko SchipperMember of Executive Committee
Rodrigo SantosMember of Executive Committee
Stefan OelrichMember of Executive Committee
Wolfgang NicklMember of Executive Committee

Board of directors

Norbert WinkeljohannChairman of Supervisory Board
Barbara GansewendtMember of Supervisory Board
Ertharin CousinMember of Supervisory Board
Norbert W. BischofbergerMember of Supervisory Board
Otmar WiestlerMember of Supervisory Board
Paul AchleitnerMember of Supervisory Board
Simone Bagel-TrahMember of Supervisory Board
Alberto WeisserMember of Supervisory Board
Andrea SacherMember of Supervisory Board
André van BroichMember of Supervisory Board
Claudia SchadeMember of Supervisory Board
Colleen GogginsMember of Supervisory Board
Francesco GrioliMember of Supervisory Board
Frank LöllgenMember of Supervisory Board
Heike HausfeldMember of Supervisory Board
Heinz Georg WebersMember of Supervisory Board
Horst Heinz Paul BaierMember of Supervisory Board
Kimberly Marie Lein-MathisenMember of Supervisory Board
Michael WestmeierMember of Supervisory Board
Yasmin FahimiMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer